HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 113 filers reported holding HARROW HEALTH INC in Q2 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,676,820 | +160.7% | 80,269 | +65.1% | 0.00% | – |
Q1 2024 | $643,269 | +5.9% | 48,622 | -10.3% | 0.00% | – |
Q4 2023 | $607,275 | +4.9% | 54,221 | +34.6% | 0.00% | – |
Q3 2023 | $579,039 | -71.2% | 40,295 | -61.8% | 0.00% | – |
Q2 2023 | $2,009,920 | +26.1% | 105,563 | +40.2% | 0.00% | – |
Q1 2023 | $1,593,538 | +2209.5% | 75,309 | +642.6% | 0.00% | – |
Q1 2022 | $69,000 | -33.7% | 10,141 | -16.1% | 0.00% | – |
Q4 2021 | $104,000 | -78.4% | 12,089 | -76.7% | 0.00% | – |
Q2 2021 | $482,000 | +79.2% | 51,919 | +30.5% | 0.00% | – |
Q1 2021 | $269,000 | +19.0% | 39,786 | +20.8% | 0.00% | – |
Q4 2020 | $226,000 | +189.7% | 32,938 | +135.7% | 0.00% | – |
Q3 2020 | $78,000 | -81.7% | 13,973 | -82.9% | 0.00% | – |
Q2 2020 | $426,000 | -28.0% | 81,913 | -47.1% | 0.00% | – |
Q1 2020 | $592,000 | +341.8% | 154,849 | +796.2% | 0.00% | – |
Q4 2019 | $134,000 | -24.3% | 17,278 | -15.2% | 0.00% | – |
Q2 2019 | $177,000 | -11.1% | 20,379 | -49.1% | 0.00% | – |
Q1 2019 | $199,000 | – | 40,029 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,710,000 | $14,119,000 | 2.85% |
Diametric Capital, LP | 288,238 | $1,502,000 | 1.15% |
Birchview Capital, LP | 180,000 | $938,000 | 0.57% |
Sio Capital Management, LLC | 238,623 | $1,243,000 | 0.36% |
CORRADO ADVISORS, LLC | 43,400 | $226,000 | 0.20% |
CADENCE CAPITAL MANAGEMENT LLC | 241,450 | $1,258,000 | 0.18% |
BARD ASSOCIATES INC | 287,250 | $1,495,000 | 0.17% |
PRELUDE CAPITAL MANAGEMENT, LLC | 195,876 | $1,021,000 | 0.06% |
Uniplan Investment Counsel, Inc. | 151,305 | $788,000 | 0.06% |
HighVista Strategies LLC | 10,300 | $54,000 | 0.04% |